The Board of Directors at its meeting held today which commenced at 11:30 am and concluded at 1:45 pm inter-alia considered and approved the following 1) Unaudited financial Result for the quarter ended June 30, 2020 along with Limited Review Report attached herewith. 2) Date and Time of 5th Annual General Meeting of the Company to be held through Video Conferencing (VC)/ other audio Visual Means (OAVM). 3) Notice of 5th Annual General Meeting along with Directors Report for the financial year 2019- 2020. 4) Appointment of Amit R. Dadheech & Associates, Practicing Company Secretaries to act as a Scrutinizer for 5th Annual General Meeting of the company

pdf

Lasa Supergenerics Ltd.

27 Jul 2020

14.35

-9.63%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for The Quarter Ended June 30, 2020

BSE India

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2020 ,inter alia, to consider and approve take on record Unaudited Financial Results along with the Limited Review Report of the Company for the quarter ended June 30, 2020 and/or to discuss any other business/matter with the permission of the Chair.

pdf

Lasa Supergenerics Ltd.

21 Jul 2020

14.35

-9.63%

Company Update

Lasa Supergenerics Ltd - 540702 - Shareholding for the Period Ended June 30, 2020

BSE India

Lasa Supergenerics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here

Lasa Supergenerics Ltd.

15 Jul 2020

14.35

-9.63%

Company Update

Lasa Supergenerics Ltd - 540702 - Statement Of Investor Complaints For The Quarter Ended June 2020

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Nidhi KulshresthaDesignation :- Company Secretary and Compliance Officer

Lasa Supergenerics Ltd.

15 Jul 2020

14.35

-9.63%

Company Update

Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2020 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company.

pdf

Lasa Supergenerics Ltd.

04 Jul 2020

14.35

-9.63%

Company Update

Lasa Supergenerics Ltd - 540702 - Compliance Under Regulation 23(9) Of SEBI (Listing Obligations & Disclosure …

BSE India

Pursuant to Regulation 23 [9] of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015, please find enclosed herewith disclosure of related party transactions for the year ended 31 March 2020.

pdf

Lasa Supergenerics Ltd.

01 Jul 2020

14.35

-9.63%

SAST

Lasa Supergenerics Ltd - 540702 - Closure of Trading Window

BSE India

This is to inform you that as per the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders in terms of (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the equity shares of the Company has been closed for designated employees and their immediate relatives w.e.f.July 01, 2020 till 48 hours after the declaration of financial results (both days inclusive) for the quarter ended June 30, 2020.

pdf

Is Lasa Supergenerics Ltd. worth buying?

51 Votes:

Buy 76.47%

Sell 17.65%

Hold 5.88%

New 52W Low today

High volume+loss today

Lasa Supergenerics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Lasa Supergenerics Ltd. on BSE